Markella Zannikou Selected Research

Markella Zannikou Research Topics

Disease

17	Neoplasms (Cancer) 04/2024 - 11/2019
5	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 11/2019
5	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2020
5	Glioma (Gliomas) 01/2023 - 11/2019
3	Triple Negative Breast Neoplasms 02/2024 - 01/2021
2	Disease Progression 02/2024 - 09/2023
2	Bites and Stings (Sting) 01/2023 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 01/2017
1	Immunoglobulin G4-Related Disease 01/2024
1	Melanoma (Melanoma, Malignant) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Diffuse Intrinsic Pontine Glioma 01/2021
1	Inflammation (Inflammations) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 02/2020
1	Neoplasm Metastasis (Metastasis) 02/2020
1	Colorectal Neoplasms (Colorectal Cancer) 02/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2017

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 02/2024 - 01/2021
3	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2023
2	InterferonsIBA 04/2024 - 01/2023
2	CytokinesIBA 02/2024 - 09/2023
2	AntigensIBA 01/2024 - 01/2023
2	Interleukin-15 (Interleukin 15)IBA 01/2023 - 01/2023
2	B7-H1 AntigenIBA 01/2023 - 11/2019
2	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2023 - 02/2020
2	Lipid NanoparticlesIBA 01/2023 - 11/2019
2	Liposomes (Liposome)IBA 01/2022 - 07/2021
1	ProhibitinsIBA 01/2024
1	Caspase 3 (Caspase-3)IBA 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	Single-Domain AntibodiesIBA 01/2022
1	liposomal doxorubicin (Doxil)FDA Link 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 07/2021
1	Coloring Agents (Dyes)IBA 07/2021
1	antiglomerular basement membrane antibodyIBA 01/2021
1	dipinacoline glutamateIBA 01/2021
1	SurvivinIBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	ProdrugsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 02/2020
1	Interleukin-13IBA 02/2020
1	Tyrosine (L-Tyrosine)FDA Link 02/2020
1	Proteins (Proteins, Gene)FDA Link 02/2020
1	claramineIBA 02/2020
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2020
1	PoisonsIBA 01/2020
1	ribosomal protein S11IBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	LipidsIBA 01/2017

Therapy/Procedure

4	Therapeutics 02/2024 - 01/2023
3	Radiotherapy 01/2023 - 11/2019
2	Immunotherapy 01/2023 - 11/2019
1	Ligation 01/2023
1	Precision Medicine 01/2022
1	Cranial Irradiation 01/2022
1	Oncolytic Virotherapy 01/2021